Familial Exudative Vitreoretinopathy With and Without Pathogenic Variants of Norrin/β-Catenin Signaling Genes

Kondo, Hiroyuki; Tsukahara-Kawamura, Tomoko; Matsushita, Itsuka; Nagata, Tatsuo; Hayashi, Takaaki; Nishina, Sachiko; Higasa, Koichiro; Uchio, Eiichi; Kondo, Mineo; Sakamoto, Taiji; Kusaka, Shunji

doi:10.1016/j.xops.2024.100514

Cited by 2 publications

(1 citation statement)

References 73 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Several families carry variants in genes encoding proteins known to directly interact with each other. Variants in FZD4 and LRP5 were found in families 27 and 36; digenic inheritance for exudative vitreoretinopathy (EVR) involving variants in these genes has been reported previously [ 47 , 48 ]. Similarly, digenic inheritance for oculocutaneous albinism (OCA) with variants in TYR and OCA2 has been suggested previously [ 49 , 50 ].…”

Section: Discussionmentioning

confidence: 95%

Limited Added Diagnostic Value of Whole Genome Sequencing in Genetic Testing of Inherited Retinal Diseases in a Swiss Patient Cohort

Maggi,

Koller,

Feil

et al. 2024

IJMS

View full text Add to dashboard Cite

The purpose of this study was to assess the added diagnostic value of whole genome sequencing (WGS) for patients with inherited retinal diseases (IRDs) who remained undiagnosed after whole exome sequencing (WES). WGS was performed for index patients in 66 families. The datasets were analyzed according to GATK’s guidelines. Additionally, DeepVariant was complemented by GATK’s workflow, and a novel structural variant pipeline was developed. Overall, a molecular diagnosis was established in 19/66 (28.8%) index patients. Pathogenic deletions and one deep-intronic variant contributed to the diagnostic yield in 4/19 and 1/19 index patients, respectively. The remaining diagnoses (14/19) were attributed to exonic variants that were missed during WES analysis due to bioinformatic limitations, newly described loci, or unclear pathogenicity. The added diagnostic value of WGS equals 5/66 (9.6%) for our cohort, which is comparable to previous studies. This figure would decrease further to 1/66 (1.5%) with a standardized and reliable copy number variant workflow during WES analysis. Given the higher costs and limited added value, the implementation of WGS as a first-tier assay for inherited eye disorders in a diagnostic laboratory remains untimely. Instead, progress in bioinformatic tools and communication between diagnostic and clinical teams have the potential to ameliorate diagnostic yields.

show abstract